Gastroparesis Claims Surge as Ozempic Lawsuits Grow Nationwide
At Rueb Stoller Daniel, we represent clients across the country in mass tort and class action cases. We are a team of experienced mass tort attorneys committed to helping individuals harmed by dangerous drugs and medical devices. We serve on multiple Plaintiff Steering Committees and take on complex litigation to fight for justice. We offer free consultations, charge no fees unless we win, and work hard to hold drug manufacturers accountable for the harm they cause.
Patients prescribed Ozempic are filing lawsuits after suffering severe gastrointestinal injuries, including gastroparesis, also known as stomach paralysis. These legal claims accuse drug manufacturers of failing to warn about serious side effects like delayed gastric emptying, vomiting, and long-term stomach pain. As more individuals report these complications, the number of gastroparesis claims linked to Ozempic continues to rise.
In this blog, you will learn how Ozempic may be linked to gastroparesis, what symptoms to watch for, the current state of Ozempic litigation, and how working with an experienced mass tort attorney can help you pursue a legal claim.
What Is Gastroparesis and Why Is It Serious?
Gastroparesis is a serious gastrointestinal condition that is now central to many Ozempic lawsuits. Patients taking Ozempic or other GLP-1 diabetes medications have reported symptoms that point to delayed gastric emptying and stomach paralysis, leading to a rise in gastroparesis claims across the United States.
What Is Gastroparesis?
Gastroparesis is a condition where the stomach takes too long to empty food into the small intestine. This delay happens without any physical blockage. Instead, the stomach muscles do not work properly, which slows digestion. This is called delayed gastric emptying. It can lead to serious health complications and affect overall digestive function.
Common Symptoms of Gastroparesis
Patients with gastroparesis may suffer from:
- Severe nausea
- Stomach pain
- Abdominal bloating
- Acid reflux
- Vomiting undigested food
- Sudden weight loss
- Feeling full after small meals
These symptoms can become chronic. Many patients struggle to maintain proper nutrition and may require long-term care.
Link to Ozempic and Other GLP-1 Drugs
Gastroparesis has been reported by diabetic patients and weight loss drug users who were prescribed Ozempic. The drug slows stomach motility as part of its mechanism to reduce appetite and control blood glucose levels. However, this effect can lead to severe gastrointestinal injuries in some users.
The U.S. Food and Drug Administration (FDA) has received adverse event reports connecting Ozempic to stomach emptying problems. Some lawsuits claim that drug manufacturers failed to warn patients about this risk.
Why Gastroparesis Is a Serious Health Concern
Gastroparesis can result in ongoing medical problems. Patients may require feeding tubes, gastric emptying studies, and long-term medication. In some cases, delayed stomach emptying causes food to ferment in the stomach, increasing the risk of bacterial infections and pulmonary aspiration.
Ozempic: What You Need to Know
Ozempic is a diabetes drug that has become the subject of legal claims involving gastroparesis, stomach paralysis, and other serious health complications.
What Is Ozempic?
Ozempic is a prescription drug used to treat type 2 diabetes. It belongs to a class of medications known as GLP-1 receptor agonists. These drugs help lower blood glucose levels by increasing insulin production and slowing gastric emptying. Ozempic has also been prescribed for weight management, leading to increased use among non-diabetic patients.
How Ozempic Works in the Body
Ozempic mimics the hormone GLP-1, which helps regulate blood sugar and appetite. One effect of this mechanism is a delay in stomach emptying. For some patients, this delay leads to serious gastrointestinal issues, including gastroparesis. The slowed stomach motility can cause severe symptoms such as stomach pain, nausea, and vomiting.
Adverse Effects Reported by Ozempic Users
Many Ozempic users have reported adverse effects linked to delayed gastric emptying. Common complaints include:
- Severe vomiting
- Abdominal pain
- Acid reflux
- Rapid weight loss
- Bloating
- Food intolerance
In more severe cases, patients have developed gastroparesis and other long-term complications. Some also report vision loss tied to conditions like nonarteritic anterior ischemic optic neuropathy.
Growing Concerns and Legal Claims
As the number of serious health complications grows, Ozempic litigation has expanded. Filed Ozempic lawsuits claim that the drug manufacturers failed to provide adequate warnings about the risk of severe gastrointestinal injuries. The legal claims highlight a lack of safety information provided to both patients and healthcare providers.
Mass tort attorneys are reviewing cases involving stomach paralysis, delayed gastric emptying, and vision loss. These lawsuits are part of ongoing multidistrict litigation involving Ozempic and other GLP-1 medications.
Why Patients Are Taking Legal Action
Ozempic users who experienced severe symptoms are filing lawsuits for financial compensation. Claims include medical costs, lost wages, and long-term disability. Many plaintiffs allege that they were not properly warned about the risks associated with taking Ozempic. The rise in gastroparesis claims reflects serious concerns about the safety of this diabetes and weight loss drug.
Link Between Ozempic and Gastroparesis
Gastroparesis is one of the most reported complications in Ozempic lawsuits, with claims focusing on delayed gastric emptying and severe gastrointestinal injuries.
What Patients Are Reporting
Many Ozempic users have reported symptoms consistent with gastroparesis. These include chronic nausea, stomach pain, vomiting, and bloating. In some cases, symptoms became so severe that patients required hospitalization or feeding tubes. Reports also mention sudden weight loss and acid reflux, which are linked to poor stomach motility.
How Ozempic May Cause Gastroparesis
Ozempic slows the movement of food through the stomach as part of its intended effect to help regulate blood sugar and appetite. For some users, this delay in stomach emptying has led to gastroparesis. Medical experts have expressed concerns that long-term use of GLP-1 drugs may interfere with the stomach’s ability to function properly.
Gastric emptying studies have been used to diagnose this condition in many patients prescribed Ozempic. These tests show significantly slowed digestion in affected individuals.
Manufacturer’s Duty to Warn
Lawsuits claim that Novo Nordisk, the maker of Ozempic, failed to provide adequate warnings about the risk of serious gastrointestinal issues. Plaintiffs allege that they were not told about the possibility of developing gastroparesis or stomach paralysis. The warning label did not clearly explain the extent of the risk.
This lack of disclosure is central to many filed Ozempic lawsuits. Legal claims point to a failure to protect patients from preventable health complications.
Medical Evidence and Legal Action
There is growing medical and legal evidence connecting Ozempic to gastroparesis. Adverse event reports submitted to the FDA support claims of stomach motility problems in Ozempic users. Some mass tort lawyers are using these reports, along with expert medical testimony, to strengthen their cases.
Ozempic Lawsuits and the State of Litigation
Ozempic lawsuits are increasing across the United States, with plaintiffs alleging that the drug caused gastroparesis and other serious health complications.
Why People Are Filing Ozempic Lawsuits
Patients taking Ozempic have filed lawsuits after experiencing delayed gastric emptying, stomach paralysis, severe vomiting, and long-term gastrointestinal injuries. Many of these individuals were not warned about the potential risks before taking the medication. Claims often focus on the failure of drug manufacturers to disclose side effects linked to GLP-1 drugs.
Plaintiffs include diabetic patients and individuals prescribed Ozempic for weight management. The lawsuits claim that drug companies did not provide adequate warnings to patients or healthcare providers.
Key Claims in Current Legal Action
Common legal claims include:
- Gastroparesis caused by Ozempic
- Lack of adequate warning labels
- Long-term medical costs from severe gastrointestinal issues
- Pain and suffering
- Loss of income due to ongoing health problems
Many lawsuits also involve vision loss, including cases of nonarteritic anterior ischemic optic neuropathy. These are being filed alongside gastroparesis claims.
Role of Multidistrict Litigation (MDL)
Ozempic cases are being consolidated into multidistrict litigation to manage similar claims more efficiently. The MDL process helps coordinate legal action from multiple plaintiffs across different states. This structure is commonly used in mass tort litigation involving prescription drugs and medical injuries.
The Ozempic MDL includes lawsuits related to delayed gastric emptying, vision loss, and other serious complications. The number of lawsuits continues to grow as more adverse event reports are filed.
Manufacturers Under Legal Pressure
Novo Nordisk and other drug manufacturers face increasing legal pressure over their failure to warn patients about the risks of Ozempic. Lawsuits claim that companies prioritized sales over safety by promoting the drug without proper risk disclosure.
Mass tort attorneys argue that warning labels were vague or incomplete, especially concerning gastroparesis and stomach motility issues. As more evidence emerges, these legal claims are expected to strengthen.
What to Expect Moving Forward
There is no Ozempic settlement yet, but litigation is active. Plaintiffs may receive compensation for medical expenses, lost income, and long-term health effects. The outcome of the MDL may also influence future claims related to other GLP-1 drugs.
Consult an Experienced Ozempic Lawsuit Attorney Today!
If you or someone you care about has suffered from gastroparesis, delayed gastric emptying, or other serious gastrointestinal injuries after taking Ozempic, our team at Rueb Stoller Daniel is here to help. We understand the impact these health complications can have on your life and are actively reviewing claims related to Ozempic lawsuits.
Contact us at 1-866-CALL-RSD for a free case consultation today!
